Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Cary Chapman

Orthopaedic Surgery Plantation, FL Medical Doctor

NPI 1689773293 CMS profile 122168

1228 S Pine Island Rd Ste 310, Plantation, FL 33324

Open in the dashboard

General payments

$130,566

180 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cary Chapman of Plantation, FL is reported in the CMS Open Payments database as having received $130,566 across 180 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $53,247 44
2024 General $39,752 47
2023 General $15,753 28
2022 General $5,784 12
2021 General $11,372 19
2020 General $2,055 14
2019 General $2,604 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cary Chapman
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Cary Chapman were reported at $53,247. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Cary Chapman Orthopaedic Surgery median Middle half National median
2019 $2,604 $644 $140–$2,844 $163
2020 $2,055 $312 $75–$1,860 $114
2021 $11,372 $520 $117–$2,495 $132
2022 $5,784 $598 $128–$2,731 $149
2023 $15,753 $461 $128–$2,264 $160
2024 $39,752 $497 $134–$2,475 $164
2025 $53,247 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novastep Inc. $62,658 50 payments
  2. Trilliant Surgical LLC. $26,537 28 payments
  3. In2Bones USA, LLC $11,682 6 payments
  4. MedShape, Inc. $6,364 12 payments
  5. Encore Medical, LP $6,344 3 payments
  6. Royal Biologics $5,137 17 payments
  7. Flower Orthopedics Coporation $4,419 5 payments
  8. Southern Edge Orthopaedics, Inc. $1,433 3 payments
  9. Arthrex, Inc. $1,319 17 payments
  10. International Life Sciences $1,246 1 payment
  11. Other $3,428 38 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $85,808 41 payments
  2. Travel and Lodging $30,935 32 payments
  3. Food and Beverage $8,106 103 payments
  4. Honoraria $2,500 1 payment
  5. Education $2,017 2 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,200 1 payment
Products named General payments · program years 2019–2025
  1. NEXIS Joint Implants $50,921 38 payments
  2. NEXIS Joint Implants $24,748 5 payments
  3. AIRLOCK CENTROLOCK $19,049 17 payments
  4. Arsenal Sinus Support Plate $12,501 2 payments
  5. Arsenal Ankle $12,501 2 payments
  6. Minimally Invasive Bunion Plate, Left $12,121 22 payments
  7. PECAPLASTY $9,038 2 payments
  8. CoLink $6,192 2 payments
  9. CoLag $6,192 2 payments
  10. NeoSpan $6,134 1 payment
  11. Other $47,380 121 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

30

Median for Orthopedic Surgery: 203

Drug cost

$351

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 11 $254
Ibuprofen Generic 19 $96

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$99,061

Of which drugs: $19

Medicare patients

305

Average age 72

Services billed

1,153

210 women, 95 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 72%
High blood pressure 65%
Ischemic heart disease 33%
Osteoporosis 27%
Depression 21%
Diabetes 18%
Chronic kidney disease 17%
Cancer 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 23 26 $19

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record